INTRODUCTION: Psychotropic drugs are frequently used in the population and account for a big share of the Spanish health budget. This study aims to describe the patterns of use of psychotropic drugs in the Spanish general population and its relationship with mental health. METHODS: A stratified, multistage, clustered area, probability sample design was used and 5,473 non-institutionalized individuals older than 18 were randomly selected among the Spanish population. They were administered the Spanish version of the World Health Organization- Composite International Diagnostic Interview (CIDI 3.0). Information on previous 12-months psychiatric symptoms and psychotropic drugs use was obtained. The proportion of individuals using psychotropic drugs was estimated and stratified according mental health diagnosis. Multivariate analyses were carried out in order to assess the influence of sociodemographic factors on use. RESULTS: 16% of the sample had used some psychotropic drug. Benzodiacepines (11.4 %) and antidepressants (4.7%) were the most commonly used and the most common combination (1.8%). Women showed the highest use of any drug (odds ratio [OR]: 2.1; 95 confidence interval [CI]: 1.7-2.5), benzodiacepines (OR: 2.3; 95 CI: 1.9-2.8), antidepressants (OR: 2.2; 95 CI: 1.6-3.1) and antipsychotics (OR: 1.9; 95 CI: 1.2-3.0). The odds of use did increase with age, and was related with the presence and number of mental disorders. CONCLUSIONS: Use of psychotropic drugs in the Spanish general population is high, although many individuals with mental disorders remain untreated. Gender and age showed an association with psychotropic drug use independent of mental health.
INTRODUCTION: Psychotropic drugs are frequently used in the population and account for a big share of the Spanish health budget. This study aims to describe the patterns of use of psychotropic drugs in the Spanish general population and its relationship with mental health. METHODS: A stratified, multistage, clustered area, probability sample design was used and 5,473 non-institutionalized individuals older than 18 were randomly selected among the Spanish population. They were administered the Spanish version of the World Health Organization- Composite International Diagnostic Interview (CIDI 3.0). Information on previous 12-months psychiatric symptoms and psychotropic drugs use was obtained. The proportion of individuals using psychotropic drugs was estimated and stratified according mental health diagnosis. Multivariate analyses were carried out in order to assess the influence of sociodemographic factors on use. RESULTS: 16% of the sample had used some psychotropic drug. Benzodiacepines (11.4 %) and antidepressants (4.7%) were the most commonly used and the most common combination (1.8%). Women showed the highest use of any drug (odds ratio [OR]: 2.1; 95 confidence interval [CI]: 1.7-2.5), benzodiacepines (OR: 2.3; 95 CI: 1.9-2.8), antidepressants (OR: 2.2; 95 CI: 1.6-3.1) and antipsychotics (OR: 1.9; 95 CI: 1.2-3.0). The odds of use did increase with age, and was related with the presence and number of mental disorders. CONCLUSIONS: Use of psychotropic drugs in the Spanish general population is high, although many individuals with mental disorders remain untreated. Gender and age showed an association with psychotropic drug use independent of mental health.
Authors: V Kovess-Masfety; A Boyd; J M Haro; R Bruffaerts; G Villagut; J P Lépine; I Gasquet; J Alonso Journal: J Affect Disord Date: 2011-05-28 Impact factor: 4.839
Authors: Angela Maria Campanha; Beatriz Ravagnani; Igor André Milhorança; Márcio Antonini Bernik; Maria Carmen Viana; Yuan-Pang Wang; Laura Helena Andrade Journal: Clinics (Sao Paulo) Date: 2020-07-10 Impact factor: 2.365
Authors: Maria Ines Quintana; Sergio Baxter Andreoli; Marcela Poctich Peluffo; Wagner Silva Ribeiro; Marcelo M Feijo; Rodrigo Affonseca Bressan; Evandro S F Coutinho; Jair de Jesus Mari Journal: PLoS One Date: 2015-08-07 Impact factor: 3.240
Authors: María Isabel Santos-Pérez; Inmaculada Fierro; M Esther Salgueiro-Vázquez; María Sáinz-Gil; Luis H Martín-Arias Journal: Eur J Hosp Pharm Date: 2019-06-11
Authors: Pilar Carrasco-Garrido; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Jesús Esteban-Hernández; Alejandro Álvaro-Meca; Ana López-de Andrés; José Luis DelBarrio-Fernández; Rodrigo Jiménez-García Journal: Int J Environ Res Public Health Date: 2016-11-24 Impact factor: 3.390
Authors: César González-Blanch; Leonardo Adrián Medrano; Roger Muñoz-Navarro; Paloma Ruíz-Rodríguez; Juan Antonio Moriana; Joaquín T Limonero; Florian Schmitz; Antonio Cano-Vindel Journal: PLoS One Date: 2018-02-23 Impact factor: 3.240
Authors: Antonio Cano-Vindel; Roger Muñoz-Navarro; Cristina Mae Wood; Joaquín T Limonero; Leonardo Adrián Medrano; Paloma Ruiz-Rodríguez; Irene Gracia-Gracia; Esperanza Dongil-Collado; Iciar Iruarrizaga; Fernando Chacón; Francisco Santolaya Journal: JMIR Res Protoc Date: 2016-12-23
Authors: Fernando Navarro-Mateu; Mj Tormo; G Vilagut; J Alonso; G Ruíz-Merino; T Escámez; D Salmerón; J Júdez; S Martínez; C Navarro Journal: BMJ Open Date: 2013-12-03 Impact factor: 2.692